Joan Block, Hepatitis B Foundation

Hepatitis B: Time for Zero Tolerance


Public comment period


SECOND MEETING-MARCH 3, 2009


The National Academies Beckman Center, Irvine, California


Welcome and opening statement


Palmer Beasley, Committee Chair


Presentations to the committee


Gary Heseltine

Lead Consultant, Viral Hepatitis Team, Council of State and Territorial Epidemiologists

Surveillance Strengths and Weaknesses


William Rogers

Director of CMS, Physician’s Regulatory Issues Team

Viral Hepatitis Prevention Policies and Programs, Centers for Medicare and Medicaid (CMS)


Tanya Pagán Raggio Ashley

Director, Office of Minority Health and Health Disparities, and Chief Medical Officer, HRSA

Community Health Centers: Health Resources and Services Administration (HRSA) Policies and Programs


Daniel Raymond

Policy Director, Harm Reduction Coalition

Hepatitis C Prevention: Harm Reduction


David Bell

Associate Director for Science and Global Activities, Division of Viral Hepatitis, Centers for Disease Control and Prevention

Global Viral Hepatitis Burden: Implications for the US and CDC Response



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement